Technical Data Sheet
NAD+
Also Known As: Nicotinamide adenine dinucleotide, NAD, NAD+ coenzyme, NAD plus, Beta-nicotinamide adenine dinucleotide, NAD IV therapy, NAD infusion, Oxidized NAD, Coenzyme I, DPN (diphosphopyridine nucleotide), NAD supplement, NADH precursor, Cellular energy coenzyme, Sirtuin activator cofactor, Anti-aging NAD, Nicotinamide Adenine Dinucleotide, NAD+, anti-aging
Scan To View Profile
| Evidence Tier | Research Compound |
|---|---|
| Category | Anti-Aging & Longevity |
| Class | Essential coenzyme (dinucleotide); critical redox electron carrier in all living cells |
| Molecular Target | Sirtuin deacetylases (SIRT1-7); PARP1 for DNA repair; CD38/CD157 signaling; NADH/NAD+ redox balance in mitochondria |
| Sequence | dinucleotide |
| Molecular Weight | ~663.43 g/mol |
| CAS | 53-84-9 |
| Parent | Endogenous coenzyme |
| Mechanism | It acts as the critical coenzyme in the mitochondria required to produce ATP (cellular energy). Restoring NAD+ levels directly increases cellular energy output and activates anti-aging repair genes (sirtuins). |
| Studied For | Aging / cellular senescence, Mitochondrial / metabolic dysfunction, Neurodegeneration models, Sirtuin activation (SIRT1-7), DNA repair (PARP activation), Addiction / substance withdrawal research, Chronic fatigue / energy restoration, Alzheimer's and Parkinson's research, Alcohol use disorder detox, Metabolic syndrome, Insulin resistance, Cardiovascular disease models, Exercise performance and endurance, Inflammation modulation, NAD metabolism optimization, Longevity research, NAMPT upregulation, Cognitive enhancement, Depression research, energy production, anti-aging, longevity, mitochondrial function, sirtuin activator, addiction recovery, brain fog |
| Administration Route | Injection Only |
| Form | lyophilized |
| Diluent | sterile water; dilute and infuse slowly for IV |
| Storage Temperature | cold, dark, often -4°F |
| Light Sensitive | Yes |
| Freeze / Thaw | avoid |
| Reconstituted Shelf Life | 7 Days |
| Handling Notes | Hygroscopic; reconstituted solution is unstable. |
| Regulatory | Not FDA-approved (compounded injectable); oral precursors sold as supplements. |
| Sources |